Continue to Site

Ancora Heart raises $80M for ventricular restoration system

July 19, 2021 By Sean Whooley

Ancora Heart announced today that it raised $80 million in equity financing for its AccuCinch ventricular restoration system.

Santa Clara, Calif.-based Ancora Heart said in a news release that funds raised in the equity round are earmarked for the acceleration of the Corcinch-HF pivotal clinical study of the AccuCinch system for treating symptomatic heart failure with reduced ejection fraction (HFrEF).

Get the full story at our sister site, MassDevice.

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.